Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alcon makes milestone payment to Pharmacyclics for Optrin

Feb. 1, 2000

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Jan. 19, 2000

Pharmacia & Upjohn seeks approval for combination glaucoma therapy

Jan. 11, 2000

Inspire's dry eye product enters phase II testing

Jan. 10, 2000

Allergan's therapy for allergic conjunctivitis approved for U.S. marketing

Dec. 27, 1999

Milestone reached by Xoma in collaboration with Allergan

Dec. 27, 1999

Allergan expands ophthalmic allergy product portfolio

Dec. 21, 1999

Swiss regulatory authorities grant Visudyne Therapy its first approval

Dec. 20, 1999

Pharmos seeks approval for Loterox in the U.K.

Dec. 20, 1999

New to the U.K. market: ophthalmic steroid from Alcon causes less IOP elevation

Dec. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 24, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 24, 2025
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...